About IPM

IPM’s mission: To prevent HIV transmission by accelerating the development and availability of safe and effective microbicides and other HIV prevention methods for use by women in developing countries.

IPM: Working to Prevent HIV in Women

Founded in 2002 as a product development partnership (PDP), IPM has become an important partner in the microbicide field. By coupling the public sector’s commitment to advancing global public health with the business approach of the private sector, IPM fills a special niche in the microbicide field.

Since our inception, IPM has focused our efforts on developing antiretroviral (ARV)-based microbicides and other products in collaboration with our partners:

• leading pharmaceutical and biotechnology companies
• philanthropic foundations
• local research centers in developing countries
• civil society organizations
• academic institutions

Using a “best practices” approach to its work, IPM:

• evaluates promising compounds
• designs optimal formulations
• conducts preclinical and clinical trials
• identifies appropriate regulatory pathways for products
• establishes manufacturing and distribution capacity to ensure access to future products

IPM also engages and collaborates with advocates and global health leaders to raise awareness about microbicides and HIV prevention products worldwide.

Through our working partnerships at the local and national level in developing countries, IPM has helped build health research infrastructure in parts of the world where the need for health research is greatest.

Microbicides: An Important Part of the Solution

HIV/AIDS is one of the world’s most serious and immediate threats to women’s health.

IPM is committed to providing women with affordable and self-initiated HIV-prevention strategies to reduce HIV transmission and, one day, to halt the disease that has already claimed the lives of more than 25 million people worldwide.

Learn more about HIV/AIDS and women, and IPM's work.